Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies
Actelis Networks, Inc. (ASNS)
Last actelis networks, inc. earnings: 11/9 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.arsanis.com/investor-relations
Company Research
Source: Business Wire
Patents strengthen Company’s intellectual property portfolio for its lead product candidate ASN100 which is designed to uniquely address Staphylococcus aureus infections WALTHAM, Mass. & VIENNA--(BUSINESS WIRE)-- Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced that the United States Patent and Trademark Office ("USPTO") issued U.S. Patent No. 9914767 to the company. This patent broadly claims composition of matter for antibodies that cross-neutralize Staphylococcus aureus alpha hemolysin (Hla) and up to four additional S. aureus leukocidins targeted by ASN-1, one of the two antibodies in the company’s lead product candidate, ASN100. ASN100 is a combination of two fully human monoclonal antibodies (mAbs) that together neutralize the six cytotoxins critical to S. aureus pn
Show less
Read more
Impact Snapshot
Event Time:
ASNS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASNS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASNS alerts
High impacting Actelis Networks, Inc. news events
Weekly update
A roundup of the hottest topics
ASNS
News
- Actelis Networks Reports Fiscal Full Year 2023 Results [Yahoo! Finance]Yahoo! Finance
- Actelis Networks Reports Fiscal Full Year 2023 ResultsGlobeNewswire
- Actelis Networks and Netceed Sign Partnership Agreement to Extend Actelis' Hybrid-Fiber Networking Solutions to Netceed's North American Customer Base [Yahoo! Finance]Yahoo! Finance
- Actelis Networks and Netceed Sign Partnership Agreement to Extend Actelis’ Hybrid-Fiber Networking Solutions to Netceed’s North American Customer BaseGlobeNewswire
- Actelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber Security [Yahoo! Finance]Yahoo! Finance
ASNS
Sec Filings
- 3/26/24 - Form S-1/A
- 3/26/24 - Form 8-K
- 3/26/24 - Form 10-K
- ASNS's page on the SEC website